Newswise — As BBI Solutions (BBI) prepare for its 25th consecutive attendance at AACC, visitors to the BBI booth can expect to discover the increasing importance of high quality biological raw materials in driving assay performance and how BBI’s new, innovative products can help achieve this.
BBI will be presenting their complete range of high quality biological raw materials, assay development expertise and new innovations in assay manufacturing services, as well as showcasing their latest products.
New products to the range include high purity Intrinsic Factor, a critical reagent in vitamin B12 assays. The BBI Intrinsic Factor represents a high performing product with stable supply and meets a specific need in the market. A new enzyme to meet the growing demands of accuracy in blood glucose monitoring is launching with our next generation FAD-GDH with reduced xylose interference. This new enzyme joins our market leading Glucose Oxidase and 1st generation FAD-GDH. Finally, a new recombinant NGAL protein for the early diagnosis of acute kidney injury, which has low dimer content, and >96% purity with a faster response time compared to other standard biomarkers.
“Using high quality raw materials really does make a difference when trying to optimise the performance of your assay,” explains Simon Packer, Technical Manager at BBI “and in an industry with tightening regulatory requirements, the need for accurate results is essential,” continues Simon, who will be attending AACC next month.
The company will also take this opportunity to showcase their expanded assay development and manufacturing services. In addition to contract assay development and manufacturing, BBI will now be offering full third party regulatory ownership and post market support – a truly unique, end to end and modular outsourced service.
Visitors interested in next generation lateral flow development will also be able to talk to BBI about 3DNA® signal amplification technology launched at the start of 2015.AACC Clinical Lab Expo is the world’s largest gathering of clinical lab professionals. This year’s event will take place on the 28th-30th July. An estimated 20,000 scientists, researchers, lab directors and decision makers from the IVD industry around the globe are expected to set foot in the Georgia World Congress Center, Atlanta.
A team of BBI Solutions’ scientists and Commercial Managers will be on hand at AACC to discuss BBI’s new products and services, as well as, discussing potential strategic partnerships, licensing and distribution deals. The team looks forward to welcoming attendees to booth #3665 and is offering an appointment booking service at its website.
Click here to arrange an appointment
RSS